Cell Source, Inc. (CLCS)

OTCMKTS: CLCS · Delayed Price · USD
0.580
+0.080 (16.00%)
Mar 27, 2024, 1:58 PM EDT - Market closed

Cell Source Market Cap

Cell Source has a market cap or net worth of $22.36 million as of March 28, 2024. Its market cap has decreased by -13.44% in one year.

Market Cap
22.36M
Enterprise Value
31.83M
1-Year Change
-13.44%
Ranking
n/a
Category
Stock Price
$0.58

Market Cap Chart

Since March 29, 2019, Cell Source's market cap has increased from $20.25M to $22.36M, an increase of 10.42%. That is a compound annual growth rate of 2.00%.

History

DateMarket Cap% Change
Mar 27, 202422.15M16.00%
Mar 26, 202419.10M-15.25%
Mar 25, 202422.53M-
Mar 22, 202422.53M-
Mar 21, 202422.53M20.41%
Mar 20, 202418.71M14.62%
Mar 19, 202416.33M39.02%
Mar 18, 202411.74M-28.49%
Mar 15, 202416.42M2.38%
Mar 14, 202416.04M5.53%
Mar 13, 202415.20M-0.50%
Mar 11, 202415.28M14.29%
Mar 8, 202413.37M-12.50%
Mar 7, 202415.28M-
Mar 5, 202415.28M-
Mar 1, 202415.28M-
Feb 28, 202415.28M-
Feb 27, 202415.28M2.56%
Feb 26, 202414.89M-15.22%
Feb 23, 202417.57M0.55%
Feb 22, 202417.47M14.38%
Feb 21, 202415.28M-
Feb 20, 202415.28M81.74%
Feb 16, 20248.41M-37.11%
Feb 15, 202413.37M-23.91%
View and export this data all the way back to 2019. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 735.08B
Novo Nordisk 579.01B
UnitedHealth Group 450.04B
Johnson & Johnson 374.07B
AbbVie 316.43B
Merck & Co. 313.67B
Thermo Fisher 222.34B
AstraZeneca 205.55B
Market Cap Rankings